This ad will auto close in 10 seconds


GSK sells anaesthetics to Aspen for up to $370 million

GSK sells anaesthetics to Aspen for up to $370 million

GlaxoSmithKline is to sell its portfolio of anaesthetic drugs to South Africa`s Aspen Pharmacare for up to 280 million pounds ($372 million) as part of a drive by the British drugmaker to focus on core therapy areas.

GlaxoSmithKline, Alphabet create $715 million bioelectronics firm

GlaxoSmithKline and Alphabet`s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics.


GSK gets EU approval for first gene therapy for children

The world`s first life-saving gene therapy for children, developed by GlaxoSmithKline and Italian scientists, was approved for sale in Europe on Friday, in a step forward for the pioneering technology to fix faulty genes.

GlaxoSmithKline CEO Witty to bow out in March 2017

Witty, a 31-year company veteran, has been under fire from some investors in the past three years as sales and profits have flagged. His reputation was further tarnished by a damaging bribery scandal in China.

Popular antidepressant neither safe nor effective for teens

Depressed teens shouldn't take the widely used antidepressant paroxetine as it is neither safe nor effective, as per a reanalysis of an influential study originally published in 2001.

GSK Pharma's Bengaluru facility to be operational by 2017

GlaxoSmithKline Pharmaceuticals (GSK India) has said its greenfield manufacturing facility at Bengaluru, having an installed capacity of over 9 billion tablets and capsules per year, will be operational by 2017.

GlaxoSmithKline targets growth across units, scraps ViiV listing

GlaxoSmithKline laid out growth targets for its biggest businesses on Wednesday, hoping to convince investors that focusing on consumer health and vaccines would return the drugmaker to long-term growth.

New-look GSK bets on consumer health spending

GSK predicted on Wednesday its consumer health sales would grow at a mid-single-digit compound annual rate over the next five years, slightly ahead of overall company sales.

Sun Pharma to buy GSK's opiates business in Australia

The business includes two manufacturing sites in Tasmania and Victoria, and consists of poppy-derived opiate raw materials mainly used to make analgesics for pain treatment. 

EU puts conditions on deals involving Novartis, GSK

The European Union on Wednesday approved mega deals involving drugmakers Novartis of Switzerland and GlaxoSmithKline of Britain, provided they sell off assets in the vaccines and consumer health businesses.

Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr

Novartis India's board on Tuesday approved the sale of its OTC division to GlaxoSmithKline Consumer Pvt Ltd, a consumer healthcare joint venture between Novartis AG and GSK, for a consideration of Rs 109.7 crore.

GSK confirms hundreds of US job cuts as market gets tougher

Many of the jobs lost will be from GSK`s Research Triangle Park site in North Carolina as drug research is consolidated in Philadelphia and in Stevenage, near London.

GSKCH picks Zubair Ahmed for global role in JV with Novartis

The company said it would make a separate announcement of the organisational structure under Ahmed.

GlaxoSmithKline slashes annual profits forecast

British drugmaker GlaxoSmithKline Wednesday slashed its 2014 profits forecast as second-quarter earnings sank on the back of weak US trade, adverse currency moves and a Chinese bribery probe.

GSK in $350 million deal to develop cancer drugs with UK biotech firm: Report

GlaxoSmithKline Plc (GSK.L) has agreed a deal worth more than USD 350 million with UK biotech company Adaptimmune to develop cancer drugs, an International Newspaper reported on Monday.

GSK-Novartis global deal not to impact India business: GSKCH

GlaxoSmithKline Consumer Healthcare shares closed at Rs 4,368 on the BSE, up 0.06 percent.

GSK slashes price of Crocin tablets

"GSKAP is reducing price of Crocin Advance Paracetamol Fast Release 500 mg tablet to conform to the price notified under DPCO, 2013 with immediate effect," GSKAP said in a statement.

Novartis India shares surge 20% in intra-day on GSK deal

Shares of Novartis India on Tuesday surged 20 percent in intra-day as global pharma major Novartis will acquire GlaxoSmithKline plc's cancer drugs portfolio for USD 16 billion and sell its vaccines business in return for USD 7.1 billion.

GSK, Novartis unveil major healthcare revamp

British pharmaceutical giant GlaxoSmithKline and Swiss peer Novartis announced a major shake-up of their healthcare divisions on Tuesday in deals worth billions of dollars.

GlaxoSmithKline Pharma Q1 Net dips 43% to Rs 96.5 cr

GlaxoSmithKline Pharmaceuticals Thursday posted 42.87 percent decline in its net profit at Rs 96.54 crore for the first quarter ended March 31, 2014, as the company continued to be impacted by the revamped price control order.